Cornerstone Robotics, a Hong Kong-based surgical robotics company, has secured a strategic partnership with Medtronic, which includes a $700 million investment. Medtronic gains distribution rights for Cornerstone's Sentire™ surgical system outside the U.S. in approved markets. This collaboration aims to increase access to minimally invasive robotic surgery worldwide by combining Cornerstone's advanced technology with Medtronic's global reach. The Sentire system has regulatory approvals in China, the EU, and Singapore, supporting various surgical specialties. The partnership is expected to accelerate development and scale-up, benefiting more patients and healthcare providers globally.
Analyst BTIG upgraded Medtronic to a Buy rating and raised its price target to $100, citing strong Q1 FY2027 revenue of $9.76 billion driven by broad demand. The company is investing over $700 million in Heart Tech and Robotics, signaling a focus on ...
Rising U.S. Treasury yields, with the 10-year surpassing 4.8%, are pressuring equities, especially growth stocks, amid concerns over fiscal deficits and potential rate hikes. Analysts expect immediate government intervention to contain long-term yiel...
Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised it...
Medtronic announced a 13.7% increase in revenue to $9.8 billion for Q1 of fiscal year 2027, driven by strong growth across cardiovascular, neuroscience, and medical surgical segments. The company raised its full-year organic revenue growth guidance t...
Medtronic has made a strategic investment of up to $80 million in Pi-Cardia, a company specializing in leaflet modification technologies for structural heart disease. This investment supports Medtronic's goal to enhance its structural heart portfolio...
